CCAM
AEHR icon

Cascades Capital Asset Management’s Aehr Test Systems AEHR Stock Holding History

Cascades Capital Asset Management’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,100
Closed -$182K – 155
2025
Q2 		$182K Buy
+14,100
New +$134K 0.09% 117

Other funds holding AEHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Cascades Capital Asset Management's AEHR Position: Q3 2025 in Review

Cascades Capital Asset Management sold out of Aehr Test Systems (AEHR) in Q3 2025, closing a stake of 14,100 shares — an estimated $182K sold.

Cascades Capital Asset Management first reported a position in AEHR in Q2 2025 and held it in 1 quarter. The position peaked at $182K in Q2 2025. 149 funds tracked by Wall St. Rank hold AEHR as of Q3 2025.

  • Cascades Capital Asset Management reported no remaining Aehr Test Systems position as of Q3 2025 after selling out during the quarter.
  • Cascades Capital Asset Management sold 14,100 Aehr Test Systems shares in Q3 2025, an estimated $182K.
  • Cascades Capital Asset Management first reported a position in Aehr Test Systems in Q2 2025 and held it in 1 quarter.
  • Cascades Capital Asset Management's Aehr Test Systems position peaked at $182K in Q2 2025.
  • 149 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2025.

Based on Cascades Capital Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.